{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:42:51Z","timestamp":1790700171717,"version":"4.1.0"},"reference-count":203,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T00:00:00Z","timestamp":1737849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Brightseed Bioactives"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic condition affecting a broad population. This review aimed to identify and summarize the current evidence on bioactive-substance-based interventions for adults with MASLD, formerly known as nonalcoholic fatty liver disease (NAFLD), covering publications from 2000 to 2023. Methods: A search was conducted across six databases (MEDLINE, CINAHL, Cochrane CENTRAL, Cochrane Database of Systematic Reviews, Food Science Source, and SPORTDiscus) for randomized controlled trials and other study types (e.g., prospective cohort studies and systematic reviews), reflecting the scoping nature of this review. The search was limited to studies in adults (&gt;18 years old), with an intervention of interest and at least one comparator group. Results: A total of 4572 articles were retrieved, with 201 full-text articles screened for eligibility. Of these, 131 primary studies and 49 systematic reviews were included in the scoping review. The most studied bioactive substances were Curcumin (Turmeric) (n = 25), Silymarin (Milk Thistle) (n = 17), Resveratrol (n = 10), Coffee (n = 7), Green Tea (n = 5), and Berberine (n = 5 each). Moreover, 46 studies reported on 36 other bioactive substances with 2 or fewer articles each. Among the included systematic reviews, 13 focused on Curcumin, 12 on Coffee or Tea, 10 on bioactive substance combinations, 6 on Resveratrol, and 2 each on Silymarin and Artichoke Leaf. The included studies showed substantial heterogeneity in reported outcomes, which primarily focused on hepatic health, body weight, adverse events, glycemic control, blood lipids, and body composition. Conclusions: This scoping review highlights a range of bioactive substances used in the treatment of MASLD. While evidence is abundant for bioactive substances like Curcumin and Silymarin, further research and synthesis of findings is necessary to establish the clinical efficacy of all bioactive substances.<\/jats:p>","DOI":"10.3390\/nu17030453","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T09:42:23Z","timestamp":1737970943000},"page":"453","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluating Bioactive-Substance-Based Interventions for Adults with MASLD: Results from a Systematic Scoping Review"],"prefix":"10.3390","volume":"17","author":[{"given":"Deepa","family":"Handu","sequence":"first","affiliation":[{"name":"Academy of Nutrition and Dietetics, Chicago, IL 60606, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Stote","sequence":"additional","affiliation":[{"name":"Department of Allied Health Sciences, State University of New York, Empire State University, Saratoga Springs, NY 12866, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tami","family":"Piemonte","sequence":"additional","affiliation":[{"name":"Academy of Nutrition and Dietetics, Chicago, IL 60606, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"156028","DOI":"10.1016\/j.metabol.2024.156028","article-title":"The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus","volume":"161","author":"Zeng","year":"2024","journal-title":"Metabolism"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/advances\/nmab044","article-title":"Perspective: Framework for Developing Recommended Intakes of Bioactive Dietary Substances","volume":"12","author":"Yates","year":"2021","journal-title":"Adv. Nutr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e0552","DOI":"10.1097\/HC9.0000000000000552","article-title":"A patient-centered approach to dietary supplements for patients with chronic liver disease","volume":"8","author":"Lai","year":"2024","journal-title":"Hepatol. Commun."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: Towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int. J. Soc. Res. Methodol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1748-5908-5-69","article-title":"Scoping studies: Advancing the methodology","volume":"5","author":"Levac","year":"2010","journal-title":"Implement. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"18","author":"Peters","year":"2020","journal-title":"JBI Evid. Synth."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_8","unstructured":"Mohr, A.E., Handu, D., and Senkus, K. (2024, November 10). Adult Nutrition and Dietary Management Interventions for Metabolic Dysfunction Associated Steatotic Liver Disease: A Systematic Scoping Review. Available online: https:\/\/osf.io\/gxfcn\/."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1586\/17474124.2015.1004312","article-title":"Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease","volume":"9","author":"Abenavoli","year":"2015","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_11","first-page":"3118","article-title":"Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study","volume":"19","author":"Aller","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MEG.0000000000001369","article-title":"Treatment options for nonalcoholic fatty liver disease: A double-blinded randomized placebo-controlled trial","volume":"31","author":"Anushiravani","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/07315724.2017.1392264","article-title":"Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial","volume":"37","author":"Asghari","year":"2018","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.15171\/apb.2018.036","article-title":"Effects of pharmacologic dose of resveratrol supplementation on oxidative\/antioxidative status biomarkers in nonalcoholic fatty liver disease patients: A randomized, double-blind, placebo- controlled trial","volume":"8","author":"Asghari","year":"2018","journal-title":"Adv. Pharm. Bull."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/jrms.jrms_683_21","article-title":"Effect of silymarin on liver size and nonalcoholic fatty liver disease in morbidly obese patients: A randomized double-blind clinical trial","volume":"27","author":"Atarodi","year":"2022","journal-title":"J. Res. Med. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.cgh.2014.02.024","article-title":"Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease","volume":"12","author":"Chachay","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/s41430-018-0386-5","article-title":"A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial","volume":"73","author":"Chashmniam","year":"2019","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.dld.2014.11.015","article-title":"Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial","volume":"47","author":"Chen","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Chiurazzi, M., Cacciapuoti, N., Di Lauro, M., Nasti, G., Ceparano, M., Salomone, E., Guida, B., and Lonardo, M.S. (2022). The Synergic Effect of a Nutraceutical Supplementation Associated to a Mediterranean Hypocaloric Diet in a Population of Overweight\/Obese Adults with NAFLD. Nutrients, 14.","DOI":"10.3390\/nu14224750"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Dallio, M., Masarone, M., Romeo, M., Tuccillo, C., Morisco, F., Persico, M., Loguercio, C., and Federico, A. (2021). PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial. Front. Med., 8.","DOI":"10.3389\/fmed.2021.734847"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1002\/ptr.6424","article-title":"The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled clinical trial","volume":"33","author":"Darand","year":"2019","journal-title":"Phytother. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ctim.2019.04.014","article-title":"Nigella sativa and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Results from a randomized, double-blind, placebo-controlled, clinical trial","volume":"44","author":"Darand","year":"2019","journal-title":"Complement. Ther. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.nutres.2014.09.005","article-title":"Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease","volume":"34","author":"Faghihzadeh","year":"2014","journal-title":"Nutr. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1017\/S0007114515002433","article-title":"The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: A randomised, double-blind, placebo-controlled study","volume":"114","author":"Faghihzadeh","year":"2015","journal-title":"Br. J. Nutr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1024\/0300-9831\/a000528","article-title":"No beneficial effects of resveratrol supplementation on atherogenic risk factors in patients with nonalcoholic fatty liver disease","volume":"90","author":"Farzin","year":"2020","journal-title":"Int. J. Vitam. Nutr. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.21873\/invivo.11101","article-title":"A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells","volume":"31","author":"Federico","year":"2017","journal-title":"In Vivo"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8742075","DOI":"10.1155\/2019\/8742075","article-title":"Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients","volume":"2019","author":"Federico","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ferro, Y., Maurotti, S., Mazza, E., Pujia, R., Sciacqua, A., Musolino, V., Mollace, V., Pujia, A., and Montalcini, T. (2022). Citrus Bergamia and Cynara Cardunculus Reduce Serum Uric Acid in Individuals with Non-Alcoholic Fatty Liver Disease. Medicina, 58.","DOI":"10.3390\/medicina58121728"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ferro, Y., Montalcini, T., Mazza, E., Foti, D., Angotti, E., Gliozzi, M., Nucera, S., Paone, S., Bombardelli, E., and Aversa, I. (2020). Randomized Clinical Trial: Bergamot Citrus and Wild Cardoon Reduce Liver Steatosis and Body Weight in Non-diabetic Individuals Aged Over 50 Years. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00494"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12967-022-03579-1","article-title":"A new nutraceutical (Livogen Plus\u00ae) improves liver steatosis in adults with non-alcoholic fatty liver disease","volume":"20","author":"Ferro","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/00325481.2022.2063568","article-title":"Effect of berberine and bicyclol on Chinese patients with nonalcoholic fatty liver disease: A retrospective study","volume":"134","author":"Geng","year":"2022","journal-title":"Postgrad. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.aimed.2018.01.002","article-title":"Effects of turmeric and chicory seed supplementation on antioxidant and inflammatory biomarkers in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"5","author":"Ghaffari","year":"2018","journal-title":"Adv. Integr. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1024\/0300-9831\/a000568","article-title":"Turmeric and chicory seed have beneficial effects on\u00ac\u2020obesity markers and lipid profile in non-alcoholic fatty liver disease (NAFLD)","volume":"89","author":"Ghaffari","year":"2019","journal-title":"Int. J. Vitam. Nutr. Res. Int. Z. Fur Vitam.-Und Ernahrungsforschung. J. Int. De Vitaminol. Et De Nutr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e43193","DOI":"10.5812\/ircmj.43193","article-title":"Effects of turmeric on homocysteine and Fetuin-A in patients with nonalcoholic fatty liver disease: A randomized Double-Blind placebo-controlled study","volume":"19","author":"Ghaffari","year":"2017","journal-title":"Iran. Red Crescent Med. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"102447","DOI":"10.1016\/j.ctim.2020.102447","article-title":"A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, clinical trial","volume":"51","author":"Hariri","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"ref_36","first-page":"265","article-title":"A Placebo-Controlled Trial of Silymarin in Patients with Nonalcoholic Fatty Liver Disease","volume":"9","author":"Hashemi","year":"2009","journal-title":"Hepat. Mon."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3109\/00365521.2015.1107620","article-title":"Placebo-controlled, randomised clinical trial: High-dose resveratrol treatment for non-alcoholic fatty liver disease","volume":"51","author":"Kreuzfeldt","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"102290","DOI":"10.1016\/j.ctim.2019.102290","article-title":"Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver disease: A randomized, controlled trial","volume":"49","author":"Hosseinabadi","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"ref_39","first-page":"180","article-title":"Effects of green coffee extract supplementation on blood pressure and antioxidants status in patients with non-alcoholic fatty liver disease","volume":"21","author":"Hosseinabadi","year":"2019","journal-title":"Prog. Nutr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"100340","DOI":"10.1016\/j.hermed.2020.100340","article-title":"Effects of green coffee extract supplementation on glycemic indexes, leptin, and obesity values in patients with non-alcoholic fatty liver disease","volume":"22","author":"Hosseinabadi","year":"2020","journal-title":"J. Herb. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.clnu.2008.03.007","article-title":"Effect of green tea extract on obese women: A randomized, double-blind, placebo-controlled clinical trial","volume":"27","author":"Hsu","year":"2008","journal-title":"Clin. Nutr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"931","DOI":"10.12669\/pjms.334.12571","article-title":"Therapeutic benefits of green tea extract on various parameters in non-alcoholic fatty liver disease patients","volume":"33","author":"Hussain","year":"2017","journal-title":"Pak. J. Med. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13098-021-00731-7","article-title":"The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: A randomized double blind clinical trial","volume":"13","author":"Jarhahzadeh","year":"2021","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12986-019-0331-1","article-title":"Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): A double-blind randomized placebo-controlled clinical trial","volume":"16","author":"Rezayat","year":"2019","journal-title":"Nutr. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"8594","DOI":"10.1039\/D1FO00448D","article-title":"Co-supplementation of camelina oil and a prebiotic is more effective for in improving cardiometabolic risk factors and mental health in patients with NAFLD: A randomized clinical trial","volume":"12","author":"Kavyani","year":"2021","journal-title":"Food Funct."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jep.2019.01.009","article-title":"Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trial","volume":"234","author":"Khonche","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"ref_47","first-page":"241","article-title":"Short term effects of coffee components consumption on gut microbiota in patients with non-alcoholic fatty liver and diabetes: A pilot randomized placebo-controlled, clinical trial","volume":"19","author":"Mansour","year":"2020","journal-title":"Excli J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12937-021-00694-5","article-title":"Effects of supplementation with main coffee components including caffeine and\/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: A randomized, double-blind, placebo-controlled, clinical trial","volume":"20","author":"Mansour","year":"2021","journal-title":"Nutr. J."},{"key":"ref_49","first-page":"46","article-title":"Effect of silymarin therapy on liver aminotransferase in non-alcoholic fatty liver disease","volume":"26","author":"Memon","year":"2015","journal-title":"Med. Forum Mon."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1017\/S0007114513003784","article-title":"Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: Randomised, double-blind, placebo-controlled clinical trial","volume":"111","author":"Barrenechea","year":"2014","journal-title":"Br. J. Nutr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-3-030-73234-9_2","article-title":"Curcumin and Piperine Combination for the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind Randomized Placebo-Controlled Trial","volume":"1328","author":"Mirhafez","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.15403\/jgld-179","article-title":"Effect of phytosomal curcumin on circulating levels of adiponectin and leptin in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled clinical trial","volume":"28","author":"Mirhafez","year":"2019","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_53","first-page":"20180040","article-title":"The effect of curcumin with piperine supplementation on pro-oxidant and antioxidant balance in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial","volume":"34","author":"Mirhafez","year":"2019","journal-title":"Drug Metab. Pers. Ther."},{"key":"ref_54","first-page":"1","article-title":"Efficacy of phytosomal curcumin among patients with non-alcoholic fatty liver disease","volume":"91","author":"Mirhafez","year":"2019","journal-title":"Int. J. Vitam. Nutr. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"100190","DOI":"10.1016\/j.metop.2022.100190","article-title":"Effect of 8 Weeks milk thistle powder (silymarin extract) supplementation on fatty liver disease in patients candidates for bariatric surgery","volume":"14","author":"Mirhashemi","year":"2022","journal-title":"Metab. Open"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jbmt.2020.02.021","article-title":"Effects of non-linear resistance training and curcumin supplementation on the liver biochemical markers levels and structure in older women with non-alcoholic fatty liver disease","volume":"24","author":"Farzanegi","year":"2020","journal-title":"J. Bodyw. Mov. Ther."},{"key":"ref_57","first-page":"181","article-title":"Effects of Silymarin on Reducing Liver Aminotransferases in Patients with Nonalcoholic Fatty Liver Diseases","volume":"18","author":"Masoodi","year":"2013","journal-title":"Iran. J. Gastroenterol. Hepatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/MEG.0000000000002297","article-title":"Efficacy of omega-3-rich Camelina sativa on the metabolic and clinical markers in nonalcoholic fatty liver disease: A randomized, controlled trial","volume":"34","author":"Musazadeh","year":"2022","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e14744","DOI":"10.1111\/ijcp.14744","article-title":"Omega 3-rich Camelina sativa oil in the context of a weight loss program improves glucose homeostasis, inflammation and oxidative stress in patients with NAFLD: A randomised placebo-controlled clinical trial","volume":"75","author":"Musazadeh","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jtcme.2020.02.004","article-title":"The synergistic effect of Citrus bergamia and Cynara cardunculus extracts on vascular inflammation and oxidative stress in non-alcoholic fatty liver disease","volume":"10","author":"Musolino","year":"2020","journal-title":"J. Tradit. Complement. Med."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Naseri, K., Saadati, S., Yari, Z., Askari, B., Mafi, D., Hoseinian, P., Asbaghi, O., Hekmatdoost, A., and de Courten, B. (2022). Curcumin Offers No Additional Benefit to Lifestyle Intervention on Cardiometabolic Status in Patients with Non-Alcoholic Fatty Liver Disease. Nutrients, 14.","DOI":"10.3390\/nu14153224"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Navarro, V.J., Belle, S.H., D\u2019Amato, M., Adfhal, N., Brunt, E.M., Fried, M.W., Reddy, K.R., Wahed, A.S., Harrison, S., and on behalf of the Silymarin in NASH and C Hepatitis (SyNCH) Study Group (2019). Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0221683"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/07315724.2016.1267597","article-title":"Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases","volume":"36","author":"Navekar","year":"2017","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_64","first-page":"39","article-title":"The Effect of Berberine on Lipid Profile, Liver Enzymes, and Fasting Blood Glucose in Patients with Non-alcoholic Fatty Liver Disease (NAFLD): A Randomized Controlled Trial","volume":"36","author":"Nejati","year":"2022","journal-title":"Med. J. Islam. Repub. Iran"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/FJC.0000000000000406","article-title":"Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial","volume":"68","author":"Panahi","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-0043-100019","article-title":"Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial","volume":"67","author":"Panahi","year":"2017","journal-title":"Drug Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"15989","DOI":"10.1002\/jcb.28877","article-title":"Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial","volume":"120","author":"Panahi","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_68","first-page":"173051","article-title":"The effect of green tea extract supplementation on liver enzymes in patients with nonalcoholic fatty liver disease","volume":"2015","author":"Pezeshki","year":"2015","journal-title":"Int. J. Prev. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/19390211.2021.1874587","article-title":"The Effects of Vitamin E, Silymarin and Carnitine on the Metabolic Abnormalities Associated with Nonalcoholic Liver Disease","volume":"19","author":"Poulos","year":"2022","journal-title":"J. Diet. Suppl."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1111\/dom.13409","article-title":"No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease","volume":"20","author":"Poulsen","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/ptr.5659","article-title":"Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial","volume":"30","author":"Rahmani","year":"2016","journal-title":"Phytother. Res. PTR"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"101598","DOI":"10.1016\/j.ctcp.2022.101598","article-title":"The effect of nigella sativa supplementation on cardiometabolic outcomes in patients with non-alcoholic fatty liver: A randomized double-blind, placebo-controlled trial","volume":"48","author":"Rashidmayvan","year":"2022","journal-title":"Complement. Ther. Clin. Pract."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41430-018-0382-9","article-title":"The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease","volume":"73","author":"Saadati","year":"2019","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_74","first-page":"S8","article-title":"Comparing different non-invasive methods in assessment of the effects of curcumin on hepatic fibrosis in patients with non-alcoholic fatty liver disease","volume":"11","author":"Saadati","year":"2018","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-019-1055-4","article-title":"Curcumin and inflammation in non-alcoholic fatty liver disease: A randomized, placebo controlled clinical trial","volume":"19","author":"Saadati","year":"2019","journal-title":"BMC Gastroenterol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"102322","DOI":"10.1016\/j.ctim.2020.102322","article-title":"Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial","volume":"49","author":"Keshvari","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Safari, Z., Bagherniya, M., Khoram, Z., Ebrahimi Varzaneh, A., Heidari, Z., Sahebkar, A., and Askari, G. (2023). The effect of curcumin on anthropometric indices, blood pressure, lipid profiles, fasting blood glucose, liver enzymes, fibrosis, and steatosis in non-alcoholic fatty livers. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1163950"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3892\/ijmm.2013.1503","article-title":"Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: A double-blind placebo-controlled study","volume":"32","author":"Sakata","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1017\/S0007114520001403","article-title":"Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: A double-blind randomised controlled clinical trial","volume":"124","author":"Sangouni","year":"2020","journal-title":"Br. J. Nutr."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"102428","DOI":"10.1016\/j.ctim.2020.102428","article-title":"Effects of garlic powder supplementation on insulin resistance, oxidative stress, and body composition in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial","volume":"51","author":"Sangouni","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clnesp.2021.11.023","article-title":"Effect of Cornus mas L. fruit extract on lipid accumulation product and cardiovascular indices in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled trial","volume":"47","author":"Sangouni","year":"2022","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1002\/ptr.7199","article-title":"The effect of (Cornus mas L.) fruit extract on liver function among patients with nonalcoholic fatty liver: A double-blind randomized clinical trial","volume":"35","author":"Sangsefidi","year":"2021","journal-title":"Phytother. Res. PTR"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e12299","DOI":"10.5812\/hepatmon.45609","article-title":"Effects of green coffee bean extract supplementation on patients with non-alcoholic fatty liver disease: A randomized clinical trial","volume":"17","author":"Shahmohammadi","year":"2017","journal-title":"Hepat. Mon."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/ptr.7764","article-title":"Efficacy of curcumin plus piperine co-supplementation in moderate-to-high hepatic steatosis: A double-blind, randomized, placebo-controlled clinical trial","volume":"37","author":"Sharifi","year":"2023","journal-title":"Phytother. Res. PTR"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.2147\/DMSO.S254555","article-title":"Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial","volume":"13","author":"Soleimani","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_86","first-page":"9","article-title":"Silymarin in treatment of non-alcoholic steatohepatitis: A randomized clinical trial","volume":"5","author":"Solhi","year":"2014","journal-title":"Casp. J. Intern. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40268-015-0084-x","article-title":"Efficacy of Lifestyle Changes in Subjects with Non-Alcoholic Liver Steatosis and Metabolic Syndrome May Be Improved with an Antioxidant Nutraceutical: A Controlled Clinical Study","volume":"15","author":"Sorrentino","year":"2015","journal-title":"Drugs R D"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5812\/hepatmon.14993","article-title":"Green tea in non-alcoholic fatty liver disease: A double blind randomized clinical trial","volume":"17","author":"Tabatabaee","year":"2017","journal-title":"Hepat. Mon."},{"key":"ref_89","first-page":"559","article-title":"Effect of resveratrol on non-alcoholic fatty liver disease","volume":"18","author":"Theodotou","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.cgh.2017.04.016","article-title":"A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis","volume":"15","author":"Mahadeva","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Yan, H.-M., Xia, M.-F., Wang, Y., Chang, X.-X., Yao, X.-Z., Rao, S.-X., Zeng, M.-S., Tu, Y.-F., Feng, R., and Jia, W.-P. (2015). Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0134172"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.clnesp.2023.04.018","article-title":"Effect of Cornus mas L. fruit extract on blood pressure, anthropometric and body composition indices in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled trial","volume":"56","author":"Yarhosseini","year":"2023","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.sjbs.2020.04.037","article-title":"The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease","volume":"27","author":"Afsharinasab","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Cossiga, V., Lembo, V., Guarino, M., Tuccillo, C., Morando, F., Pontillo, G., Fiorentino, A., Caporaso, N., and Morisco, F. (2019). Berberis aristata, Elaeis guineensis and Coffea canephora Extracts Modulate the Insulin Receptor Expression and Improve Hepatic Steatosis in NAFLD Patients: A Pilot Clinical Trial. Nutrients, 11.","DOI":"10.3390\/nu11123070"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e102125","DOI":"10.5812\/hepatmon.102125","article-title":"Effect of Beta vulgaris Extract on Liver Enzymes in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial","volume":"20","author":"Afzali","year":"2020","journal-title":"Hepat. Mon."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/ptr.7446","article-title":"Effect of rosemary leaf powder with weight loss diet on lipid profile, glycemic status, and liver enzymes in patients with nonalcoholic fatty liver disease: A randomized, double-blind clinical trial","volume":"36","author":"Akbari","year":"2022","journal-title":"Phytother. Res. PTR"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.clnu.2017.05.028","article-title":"Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial","volume":"37","author":"Amanat","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e2001178","DOI":"10.1002\/mnfr.202001178","article-title":"Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial","volume":"65","author":"Amerikanou","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nutres.2013.11.005","article-title":"Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients","volume":"34","author":"Askari","year":"2014","journal-title":"Nutr. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/ijp.IJP_17_19","article-title":"Comparison of the efficacy of oral fenugreek seeds hydroalcoholic extract versus placebo in nonalcoholic fatty liver disease; a randomized, triple-blind controlled pilot clinical trial","volume":"52","author":"Babaei","year":"2020","journal-title":"Indian J. Pharmacol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12937-023-00869-2","article-title":"Pomegranate (Punica granatum L.) peel extract ameliorates metabolic syndrome risk factors in patients with non-alcoholic fatty liver disease: A randomized double-blind clinical trial","volume":"22","author":"Barghchi","year":"2023","journal-title":"Nutr. J."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Castellino, G., Nikolic, D., Mag\u00e1n-Fern\u00e1ndez, A., Malfa, G.A., Chianetta, R., Patti, A.M., Amato, A., Montalto, G., Toth, P.P., and Banach, M. (2019). Altilix\u00ae Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study. Nutrients, 11.","DOI":"10.3390\/nu11112580"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1017\/S0007114519002484","article-title":"Randomized trial of chronic supplementation with a nutraceutical mixture to subjects with Non Alcoholic Fatty Liver Disease (NAFLD)","volume":"123","author":"Cerletti","year":"2020","journal-title":"Br. J. Nutr."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/ptr.6406","article-title":"Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial","volume":"33","author":"Cheraghpour","year":"2019","journal-title":"Phytother. Res. PTR"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/07315724.2020.1779850","article-title":"Hepatoprotective Effect of Mycelium in Patients with Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"40","author":"Chiou","year":"2021","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_106","first-page":"34","article-title":"The add-on effects of Gynostemma pentaphyllum on nonalcoholic fatty liver disease","volume":"12","author":"Chou","year":"2006","journal-title":"Altern. Ther. Health Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12986-018-0297-4","article-title":"Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: A double-blind randomized placebo-controlled clinical trial","volume":"15","author":"Keshavarz","year":"2018","journal-title":"Nutr. Metab."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Daneshi-Maskooni, M., Keshavarz, S.A., Qorbani, M., Mansouri, S., Alavian, S.M., Badri-Fariman, M., Jazayeri-Tehrani, S.A., and Sotoudeh, G. (2019). Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: A double-blind randomized placebo-controlled clinical trial. BMC Complement. Altern. Med., 19.","DOI":"10.1186\/s12906-019-2465-0"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/ptr.6972","article-title":"Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double-blind clinical trial","volume":"35","author":"Shidfar","year":"2021","journal-title":"Phytother. Res. PTR"},{"key":"ref_110","first-page":"107","article-title":"The Effect of Chlorella vulgaris Supplementation on Liver Enzymes, Serum Glucose and Lipid Profile in Patients with Non-Alcoholic Fatty Liver Disease","volume":"4","author":"Aliashrafi","year":"2014","journal-title":"Health Promot. Perspect."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.clnu.2016.07.004","article-title":"Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial","volume":"36","author":"Sadeghi","year":"2017","journal-title":"Clin. Nutr."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nutres.2019.08.009","article-title":"An energy-restricted high-protein diet supplemented with \u00ce\u00b2-cryptoxanthin alleviated oxidative stress and inflammation in nonalcoholic fatty liver disease: A randomized controlled trial","volume":"73","author":"Haidari","year":"2020","journal-title":"Nutr. Res."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Haidari, F., Hojhabrimanesh, A., Helli, B., Seyedian, S.S., Ahmadi-Angali, K., and Abiri, B. (2020). A hypocaloric high-protein diet supplemented with \u03b2-cryptoxanthin improves non-alcoholic fatty liver disease: A randomized controlled trial. BMC Gastroenterol., 20.","DOI":"10.1186\/s12876-020-01502-w"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7762\/cnr.2020.9.4.258","article-title":"A Randomized, Double-Blind, Placebo-Controlled, Multi-Centered Clinical Study to Evaluate the Efficacy and Safety of Artemisia annua L. Extract for Improvement of Liver Function","volume":"9","author":"Han","year":"2020","journal-title":"Clin. Nutr. Res."},{"key":"ref_115","first-page":"433","article-title":"Clinical effect of the extract of TCM Fructus akebiae combined with ursodeoxycholic acid on nonalcoholic fatty liver disease","volume":"32","author":"Hongguang","year":"2019","journal-title":"Pak. J. Pharm. Sci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/09637486.2020.1746957","article-title":"Combined cranberry supplementation and weight loss diet in non-alcoholic fatty liver disease: A double-blind placebo-controlled randomized clinical trial","volume":"71","author":"Hormoznejad","year":"2020","journal-title":"Int. J. Food Sci. Nutr."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3904\/kjim.2013.28.4.439","article-title":"Effects of D-002, a mixture of high molecular weight beeswax alcohols, on patients with nonalcoholic fatty liver disease","volume":"28","author":"Illnait","year":"2013","journal-title":"Korean J. Intern. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ptr.6826","article-title":"Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled clinical trial","volume":"35","author":"Izadi","year":"2020","journal-title":"Phytother. Res. PTR"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"6693887","DOI":"10.1155\/2021\/6693887","article-title":"The Efficacy of Plantago major Seed on Liver Enzymes in Nonalcoholic Fatty Liver Disease: A Randomized Double-Blind Clinical Trial","volume":"2021","author":"Jazayeri","year":"2021","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Jinato, T., Chayanupatkul, M., Dissayabutra, T., Chutaputti, A., Tangkijvanich, P., and Chuaypen, N. (2022). Litchi-Derived Polyphenol Alleviates Liver Steatosis and Gut Dysbiosis in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Double-Blinded, Placebo-Controlled Study. Nutrients, 14.","DOI":"10.3390\/nu14142921"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Kanoni, S., Kumar, S., Amerikanou, C., Kurth, M.J., Stathopoulou, M.G., Bourgeois, S., Masson, C., Kannt, A., Cesarini, L., and Kontoe, M.-S. (2021). Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.683028"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"101259","DOI":"10.1016\/j.ctcp.2020.101259","article-title":"The effects of sumac (Rhus coriaria L.) powder supplementation in patients with non-alcoholic fatty liver disease: A randomized controlled trial","volume":"41","author":"Kazemi","year":"2020","journal-title":"Complement. Ther. Clin. Pract."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/1319-3767.65197","article-title":"Grape seed extract to improve liver function in patients with nonalcoholic fatty liver change","volume":"16","author":"Khoshbaten","year":"2010","journal-title":"Saudi J. Gastroenterol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jnutbio.2019.03.006","article-title":"Pinitol consumption improves liver health status by reducing oxidative stress and fatty acid accumulation in subjects with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial","volume":"68","author":"Lee","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1002\/ptr.7279","article-title":"The effects of co-administration of artichoke leaf extract supplementation with metformin and vitamin E in patients with nonalcoholic fatty liver disease: A randomized clinical trial","volume":"35","author":"Majnooni","year":"2021","journal-title":"Phytother. Res. PTR"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Masnadi Shirazi, K., Shirinpour, E., Masnadi Shirazi, A., and Nikniaz, Z. (2021). Effect of cranberry supplementation on liver enzymes and cardiometabolic risk factors in patients with NAFLD: A randomized clinical trial. BMC Complement. Med. Ther., 21.","DOI":"10.1186\/s12906-021-03436-6"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ijcp.14852","article-title":"Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight\/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial","volume":"75","author":"Namkhah","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.aimed.2020.07.013","article-title":"Effects of hydroxy citric acid on body weight and serum hepcidin level in women with non-alcoholic fatty liver disease","volume":"8","author":"Mahboob","year":"2021","journal-title":"Adv. Integr. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/ptr.6073","article-title":"Efficacy of artichoke leaf extract in non-alcoholic fatty liver disease: A pilot double-blind randomized controlled trial","volume":"32","author":"Panahi","year":"2018","journal-title":"Phytother. Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1002\/ptr.6791","article-title":"The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: A double-blind randomized clinical trial","volume":"34","author":"Pour","year":"2020","journal-title":"Phytother. Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/CEG.S234698","article-title":"Effect of Ginger Powder Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial","volume":"13","author":"Rafie","year":"2020","journal-title":"Clin. Exp. Gastroenterol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e34897","DOI":"10.5812\/hepatmon.34897","article-title":"Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study","volume":"16","author":"Rahimlou","year":"2016","journal-title":"Hepat. Mon."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1002\/ptr.7543","article-title":"Effects of licorice root supplementation on liver enzymes, hepatic steatosis, metabolic and oxidative stress parameters in women with nonalcoholic fatty liver disease: A randomized double-blind clinical trial","volume":"36","author":"Rostamizadeh","year":"2022","journal-title":"Phytother. Res. PTR"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Shih, P.H., Shiue, S.J., Chen, C.N., Cheng, S.W., Lin, H.Y., Wu, L.W., and Wu, M.S. (2021). Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin\/Adiponectin Axis. Mar. Drugs, 19.","DOI":"10.3390\/md19030148"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clnesp.2023.02.016","article-title":"Clinical effectiveness of \u03b1-lipoic acid, myo-inositol and propolis supplementation on metabolic profiles and liver function in obese patients with NAFLD: A randomized controlled clinical trial","volume":"54","author":"Tutunchi","year":"2023","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"6492478","DOI":"10.1155\/2023\/6492478","article-title":"Effects of Hydroxycitric Acid Supplementation on Body Composition, Obesity Indices, Appetite, Leptin, and Adiponectin of Women with NAFLD on a Calorie-Restricted Diet","volume":"2023","author":"Tutunchi","year":"2023","journal-title":"Int. J. Clin. Pract."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/09637486.2016.1161011","article-title":"Flaxseed supplementation in non-alcoholic fatty liver disease: A pilot randomized, open labeled, controlled study","volume":"67","author":"Yari","year":"2016","journal-title":"Int. J. Food Sci. Nutr."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41430-020-0679-3","article-title":"The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: An open-labeled randomized controlled trial","volume":"75","author":"Yari","year":"2021","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ctim.2018.09.010","article-title":"The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: A randomized double-blind placebo-controlled clinical trial","volume":"41","author":"Zamani","year":"2018","journal-title":"Complement. Ther. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.1097\/MD.0000000000000758","article-title":"A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease","volume":"94","author":"Zhang","year":"2015","journal-title":"Medicine"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Abunofal, O., and Mohan, C. (2022). Salubrious Effects of Green Tea Catechins on Fatty Liver Disease: A Systematic Review. Medicines, 9.","DOI":"10.3390\/medicines9030020"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"101349","DOI":"10.1016\/j.ctcp.2021.101349","article-title":"Effect of green coffee bean extract supplementation on liver function and inflammatory biomarkers: A meta-analysis of randomized clinical trials","volume":"43","author":"Asbaghi","year":"2021","journal-title":"Complement. Ther. Clin. Pract."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/ptr.6542","article-title":"The effects of curcumin supplementation on body mass index, body weight, and waist circumference in patients with nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis of randomized controlled trials","volume":"34","author":"Baziar","year":"2020","journal-title":"Phytother. Res."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Ebadi, M., Ip, S., Bhanji, R.A., and Montano-Loza, A.J. (2021). Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies. Nutrients, 13.","DOI":"10.3390\/nu13093042"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"59","DOI":"10.15403\/jgld.2014.1121.261.ely","article-title":"Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-analysis","volume":"26","author":"Elgebaly","year":"2017","journal-title":"J. Gastrointest. Liver Dis. JGLD"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/ijpvm.IJPVM_313_20","article-title":"Effect of Medicinal Plants and Natural Products on Liver Enzymes in Non-alcoholic Fatty Liver Patients in Iran: A Systematic Review and Meta-Analysis","volume":"13","author":"Fakhri","year":"2022","journal-title":"Int. J. Prev. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ptr.6270","article-title":"Does turmeric\/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials","volume":"33","author":"Goodarzi","year":"2019","journal-title":"Phytother. Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"E139","DOI":"10.1017\/S0029665123001489","article-title":"The effect of dietary intervention, with or without co-interventions, on inflammatory markers in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"82","author":"Hall","year":"2023","journal-title":"Proc. Nutr. Soc."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"100254","DOI":"10.1016\/j.aohep.2020.08.071","article-title":"The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies","volume":"20","author":"Hayat","year":"2021","journal-title":"Ann. Hepatol."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"He, X., Li, Y., Deng, X., Xiao, X., and Zeng, J. (2023). Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: Preclinical and clinical meta-analyses. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1230783"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7762\/cnr.2019.8.3.196","article-title":"Does Turmeric\/curcumin Supplementation Change Anthropometric Indices in Patients with Non-alcoholic Fatty Liver Disease? A Systematic Review and Meta-analysis of Randomized Controlled Trials","volume":"8","author":"Jafarirad","year":"2019","journal-title":"Clin. Nutr. Res."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Jakubczyk, K., Skonieczna-\u017bydecka, K., Ka\u0142du\u0144ska, J., Stachowska, E., Gutowska, I., and Janda, K. (2020). Effects of Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease-A Meta-Analysis. Nutrients, 12.","DOI":"10.3390\/nu12082435"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"102283","DOI":"10.1016\/j.ctim.2019.102283","article-title":"The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials","volume":"48","author":"Jalali","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"111092","DOI":"10.1016\/j.nut.2020.111092","article-title":"Impact of Silymarin in individuals with nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"83","author":"Kalopitas","year":"2021","journal-title":"Nutrition"},{"key":"ref_156","first-page":"931","article-title":"Therapeutic Potential of Artichoke in the Treatment of Fatty Liver: A Systematic Review and Meta-Analysis","volume":"25","author":"Kamel","year":"2022","journal-title":"J. Med. Food"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.2174\/1381612828666220328111141","article-title":"The Effects of Curcumin Supplementation on Metabolic Biomarkers and Body Mass Index in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials","volume":"28","author":"Khalili","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Kositamongkol, C., Kanchanasurakit, S., Auttamalang, C., Inchai, N., Kabkaew, T., Kitpark, S., Chaiyakunapruk, N., Duangjai, A., Saokaew, S., and Phisalprapa, P. (2021). Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.786596"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Kosmalski, M., Frankowski, R., Deska, K., R\u00f3\u017cycka-Kosmalska, M., and Pietras, T. (2023). Exploring the Impact of Nutrition on Non-Alcoholic Fatty Liver Disease Management: Unveiling the Roles of Various Foods, Food Components, and Compounds. Nutrients, 15.","DOI":"10.3390\/nu15132838"},{"key":"ref_160","first-page":"CD009059","article-title":"Herbal medicines for fatty liver diseases","volume":"8","author":"Liu","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Lukkunaprasit, T., Tansawet, A., Boonmanunt, S., Sobhonslidsuk, A., McKay, G.J., Attia, J., and Thakkinstian, A. (2023). An updated meta-analysis of effects of curcumin on metabolic dysfunction-associated fatty liver disease based on available evidence from Iran and Thailand. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-33023-3"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/ptr.6637","article-title":"Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized clinical trials","volume":"34","author":"Mahmoodi","year":"2020","journal-title":"Phytother. Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/ptr.6130","article-title":"Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: A systematic review and meta-analysis of clinical trials","volume":"32","author":"Hadi","year":"2018","journal-title":"Phytother. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.clnu.2016.03.012","article-title":"Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies","volume":"35","author":"Marventano","year":"2016","journal-title":"Clin. Nutr."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"102668","DOI":"10.1016\/j.ctim.2021.102668","article-title":"Effects of artichoke on blood pressure: A systematic review and meta-analysis","volume":"57","author":"Moradi","year":"2021","journal-title":"Complement. Ther. Med."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"102843","DOI":"10.1016\/j.ctim.2022.102843","article-title":"Curcumin as adjuvant treatment in patients with non-alcoholic fatty liver (NAFLD) disease: A systematic review and meta-analysis","volume":"66","author":"Ngu","year":"2022","journal-title":"Complement. Ther. Med."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Perna, S., Rafique, A., Rondanelli, M., Allehdan, S., Riso, P., and Marino, M. (2023). Effect of caper fruit (Capparis spinosa L.) consumption on liver enzymes, lipid profile, fasting plasma glucose, and weight loss. A systematic review and a preliminary meta-analysis of randomized controlled trials. Biomed. Pharmacother.=Biomed. Pharmacother., 168.","DOI":"10.1016\/j.biopha.2023.115638"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"6960211","DOI":"10.1155\/2022\/6960211","article-title":"Therapeutic Effects and Mechanisms of Action of Garlic (Allium sativum) on Nonalcoholic Fatty Liver Disease: A Comprehensive Systematic Literature Review","volume":"2022","author":"Pourreza","year":"2022","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"101281","DOI":"10.1016\/j.ctcp.2020.101281","article-title":"Efficacy of resveratrol supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials","volume":"42","author":"Rafiee","year":"2021","journal-title":"Complement. Ther. Clin. Pract."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/nutrit\/nuz029","article-title":"Effect of dietary intervention, with or without co-interventions, on inflammatory markers in patients with nonalcoholic fatty liver disease: A systematic literature review","volume":"77","author":"Reddy","year":"2019","journal-title":"Nutr. Rev."},{"key":"ref_171","first-page":"495","article-title":"Impact of coffee on liver diseases: A systematic review","volume":"34","author":"Saab","year":"2014","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Sewter, R., Heaney, S., and Patterson, A. (2021). Coffee Consumption and the Progression of NAFLD: A Systematic Review. Nutrients, 13.","DOI":"10.3390\/nu13072381"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"9715","DOI":"10.1007\/s11033-012-1836-0","article-title":"Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"39","author":"Shi","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"ref_174","first-page":"1462","article-title":"Systematic Review and Meta-analysis: The Role of Diet in the Development of Nonalcoholic Fatty Liver Disease","volume":"21","author":"Tsompanaki","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Wang, L.-L., Zhang, P.-H., and Yan, H.-H. (2023). Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1014010"},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Wang, X., Jin, X., Li, H., Zhang, X., Chen, X., Lu, K., and Chu, C. (2023). Effects of various interventions on non-alcoholic fatty liver disease (NAFLD): A systematic review and network meta-analysis. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1180016"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"102635","DOI":"10.1016\/j.ctim.2020.102635","article-title":"Efficacy of resveratrol supplementation on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"57","author":"Wei","year":"2021","journal-title":"Complement. Ther. Med."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s12072-018-9910-x","article-title":"The effects of curcumin on the metabolic parameters of non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials","volume":"13","author":"Wei","year":"2019","journal-title":"Hepatol. Int."},{"key":"ref_179","first-page":"1350","article-title":"The impact of turmeric or its curcumin extract on nonalcoholic fatty liver disease: A systematic review of clinical trials","volume":"17","author":"White","year":"2019","journal-title":"Pharm. Pract."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1097\/MEG.0000000000000776","article-title":"Coffee consumption and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"29","author":"Wijarnpreecha","year":"2017","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Yang, K., Chen, J., Zhang, T., Yuan, X., Ge, A., Wang, S., Xu, H., Zeng, L., and Ge, J. (2022). Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.949746"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/ajcn\/nqab250","article-title":"effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: An umbrella review of meta-analyses of randomized controlled trials","volume":"114","author":"Jayedi","year":"2021","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Zhang, C., Yuan, W., Fang, J., Wang, W., He, P., Lei, J., and Wang, C. (2016). Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0161792"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"e9061","DOI":"10.1097\/MD.0000000000009061","article-title":"The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta-analysis (PRISMA) of randomized control trials","volume":"96","author":"Zhong","year":"2017","journal-title":"Medicine"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"e24884","DOI":"10.1097\/MD.0000000000024884","article-title":"The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment: A PRISMA-compliant network meta-analysis of randomized controlled trials","volume":"100","author":"Zhou","year":"2021","journal-title":"Medicine"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4314\/ahs.v23i1.65","article-title":"Ginger supplementation for the treatment of non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials","volume":"23","author":"Zhou","year":"2023","journal-title":"Afr. Health Sci."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.imr.2018.07.004","article-title":"Efficacy of curcumin\/turmeric on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled trials","volume":"8","author":"Pourmasoumi","year":"2019","journal-title":"Integr. Med. Res."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"R\u00f3\u017ca\u0144ski, G., Tabisz, H., Zalewska, M., Niemiro, W., Kujawski, S., Newton, J., Zalewski, P., and S\u0142omko, J. (2023). Meta-Analysis of Exploring the Effect of Curcumin Supplementation with or without Other Advice on Biochemical and Anthropometric Parameters in Patients with Metabolic-Associated Fatty Liver Disease (MAFLD). Int J Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20054266"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"e25817","DOI":"10.1097\/MD.0000000000025817","article-title":"Soy diet for nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials","volume":"100","author":"Xiong","year":"2021","journal-title":"Medicine"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12944-023-01900-5","article-title":"The effects of medicinal and food homologous substances on blood lipid and blood glucose levels and liver function in patients with nonalcoholic fatty liver disease: A systematic review of randomized controlled trials","volume":"22","author":"Zhang","year":"2023","journal-title":"Lipids Health Dis."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Guariglia, M., Saba, F., Rosso, C., and Bugianesi, E. (2023). Molecular Mechanisms of Curcumin in the Pathogenesis of Metabolic Dysfunction Associated Steatotic Liver Disease. Nutrients, 15.","DOI":"10.3390\/nu15245053"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"189","DOI":"10.15171\/mejdd.2019.147","article-title":"Burden of Liver Diseases: A Review from Iran","volume":"11","author":"Anushiravani","year":"2019","journal-title":"Middle East J. Dig. Dis."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"101209","DOI":"10.1016\/j.jceh.2023.06.009","article-title":"Prevalence of Non-alcoholic Fatty Liver Disease in Iran: A Systematic Review and Meta-analysis","volume":"14","author":"Tabaeian","year":"2024","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/advances\/nmaa109","article-title":"Perspective: Design and Conduct of Human Nutrition Randomized Controlled Trials","volume":"12","author":"Lichtenstein","year":"2021","journal-title":"Adv. Nutr."},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Sorkin, B.C., Murch, S.J., Weaver, C.M., and Jafari, M. (2022). Editorial: Plant Foods and Dietary Supplements: Building Solid Foundations for Clinical Trials. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.881688"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"111572","DOI":"10.1016\/j.jclinepi.2024.111572","article-title":"\u201cHow-to\u201d: Scoping review?","volume":"176","author":"Pollock","year":"2024","journal-title":"J. Clin. Epidemiol."},{"key":"ref_197","first-page":"5","article-title":"The 2023 ADA Standards of Care: What\u2019s new?","volume":"25","author":"Brown","year":"2023","journal-title":"Diabetes Prim. Care"},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Ali Sangouni, A., Abdollahi, S., and Mozaffari-Khosravi, H. (2022). Effect of resveratrol supplementation on hepatic steatosis and cardiovascular indices in overweight subjects with type 2 diabetes: A double-blind, randomized controlled trial. BMC Cardiovasc. Disord., 22.","DOI":"10.1186\/s12872-022-02637-2"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clnesp.2020.06.020","article-title":"The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: A randomized, placebo-controlled, clinical trial","volume":"39","author":"Abhari","year":"2020","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"115680","DOI":"10.1016\/j.jep.2022.115680","article-title":"Uncovering the effect and mechanism of Panax notoginseng saponins on metabolic syndrome by network pharmacology strategy","volume":"300","author":"Wang","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.advnut.2023.01.001","article-title":"Effect of Dietary Intervention, with or without Cointerventions, on Inflammatory Markers in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"14","author":"Hall","year":"2023","journal-title":"Adv. Nutr. (Bethesda Md.)"},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Moradi, F., Kooshki, F., Nokhostin, F., Khoshbaten, M., Bazyar, H., and Pourghassem Gargari, B. (2021). A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial. J. Trace Elem. Med. Biol. Organ Soc. Miner. Trace Elem. (GMS), 63.","DOI":"10.1016\/j.jtemb.2020.126659"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-030-64872-5_3","article-title":"The Effect of Curcumin Phytosome on the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Trial","volume":"1308","author":"Mirhafez","year":"2021","journal-title":"Adv. Exp. Med. Biol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/3\/453\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:36:37Z","timestamp":1759919797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/3\/453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,26]]},"references-count":203,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["nu17030453"],"URL":"https:\/\/doi.org\/10.3390\/nu17030453","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,26]]}}}